Posted by Michael Wonder on 03 Nov 2019
White House distances itself from Pelosi plan to lower drug prices
2 November 2019 - The White House is distancing itself from Speaker Nancy Pelosi’s plan to lower drug prices, emphasising support for a bipartisan plan in the Senate instead.
The White House has been in talks with Pelosi’s office for months on drug prices, a rare shared priority, but the effort always faced tough odds given the partisan divide and the impeachment inquiry into President Trump.
Now the Trump administration is downplaying the chances it will endorse Pelosi’s bill, instead pointing to a somewhat more modest bill in the Senate from Senators Chuck Grassley and Ron Wyden, the chairman and ranking member, respectively, of the Senate Finance Committee.
